ZALEVSKY JONATHAN (Chief R&D Officer) sold 15.3% of their position (3.87K shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $137.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2026ACC: 0001193125-26-019843
Officer· Chief R&D Officer
Since Oct 2019
-3.87K
Net shares
Net seller
$137.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.87K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.87K
Price / share
$35.67
Trade value
$137.94K
% of position
15.3%
1/20/2026
25.22K→21.35K
Total
Net shares
−3.87K
Net value
-$137.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | S · Sale | −3.87K | $35.67 | $137.94K | 15.3% | 25.22K | 21.35K |
| Total | −3.87K | -$137.94K | ||||||
Derivative Transactions0
No derivative transactions reported